22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here

  • Home
  • About Us
    • Our Company
    • Our Leadership Team
    • Board of Directors
  • Reduced Nicotine Tobacco
    • VLN®
    • Clinical Studies & Commentaries
  • Hemp/Cannabis Innovation
    • GVB Biopharma
  • Hops Research
  • News
  • Investors
    • Overview
    • New Investor / Latest Resources
    • Events
    • News
    • Stock Data
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Annual Reports
    • FAQs
  • Contact Us

Corporate Governance

Investors

Investors

  • Overview
  • New Investor / Latest Resources
  • Events
  • News
    • Press Releases
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Trades
  • SEC Filings
  • Analyst Coverage
  • Corporate Governance
  • Annual Reports
  • FAQs

Code of Business Conduct and Corporate Ethics

Download Code of Business Conduct and Corporate Ethics

Insider Trading Policy

Download Insider Trading Policy

Audit Committee Charter

Download Audit Committee Charter

Compensation Committee Charter

Download Compensation Committee Charter

Corporate Governance & Nominating Committee Charter

Download Corporate Governance & Nominating Committee Charter

Environmental, Social, and Governance Policy

Download Environmental, Social, and Governance Policy

Finance Committee Charter

Download Finance Committee Charter

Scientific Advisory Board

Download Scientific Advisory Board

Regulation Fair Disclosure (Reg FD)

Download Regulation Fair Disclosure (Reg FD)
  • Email Alerts
  • Contact
  • RSS News Feed
© 2023 22nd Century Group, Inc. All Rights Reserved.
Privacy Policy / CCPA Disclaimer Sitemap